- 1Department of Functional Diagnosis, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
- 2Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
- 3Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China
Objective: To explore the predictive value of key preoperative cardiopulmonary exercise testing (CPET) indicators for cardiopulmonary complications following thoracoscopic lung resection.
Methods: Patients who underwent lung resection at the Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University were selected. Information was collected for patients who completed CPET using the incremental exercise protocol. Hospitalization information, postoperative complications and follow-up data were analyzed. Correlations between postoperative cardiopulmonary complications and preoperative CPET indices were analyzed to identify threshold values.
Results: Among 376 thoracoscopic lung resection patients, 52 experienced at least one complication (13.8%). Comparison between the cardiopulmonary complications group (CCP) and no complications group (NCCP) revealed significant differences in age, extent of lung resection, and lymph node metastasis (P < 0.05). Core CPET indicators including peak heart rate (peak HR), peak oxygen uptake (peak VO2), peak VO2%pred, peak metabolic equivalent (peak MET), and maximal workload %pred were significantly lower in the CCP group (P < 0.05). The sensitivity and specificity of peak VO2%pred <70%, peak MET <5, and maximal workload %pred <80% all exceeded 60%, with negative predictive values surpassing 90%. Positive predictive values of peak VO2 < 15 mL/(min·kg), peak VO2%pred <60%, peak MET <4, and maximal workload %pred < 60% exceeded 30%. Using these cutoff values resulted in high diagnostic accuracy with odds ratios of 6.2, 4.0, 4.6, and 3.2, respectively.
Conclusion: Key preoperative CPET indicators effectively evaluate postoperative complication risk in thoracoscopic lung resection patients. Peak VO2, peak VO2%pred, peak MET, and maximal workload %pred are associated with postoperative cardiopulmonary complications.
1 Introduction
Lung cancer is a malignant tumor with high incidence and mortality rates worldwide (1, 2). Surgical resection continues to be the recommended treatment for early-stage lung cancer. Thoracic complications are the main type of complication associated with lung resection, with an incidence rate ranging from approximately 10%–49% (3–9). This wide range is primarily attributed to differences in the location and stage of the primary disease, surgical methods, criteria for complication assessment, and analytical methods.
The occurrence of thoracic complications following pulmonary resection can prolong the hospitalization time, affect the long-term prognosis of the patient, and even elevate the risk of mortality. Despite advances in overall medical standards and the widespread application of minimally invasive thoracoscopic surgery, which have reduced surgical trauma, post-thoracic surgical complications remain a significant concern that affect both the recovery of the patient and the effectiveness of surgical treatment. Risk assessment is a standard component of preoperative evaluation for lung resection (10). A robust cardiopulmonary functional reserve is one of the necessary conditions for patients to tolerate lung resection surgery. Therefore, preoperative cardiopulmonary function testing is an important method for evaluating surgical indicators and assessing the risk of postoperative cardiopulmonary complications.
Cardiopulmonary exercise testing (CPET) is an objective, quantitative, and non-invasive method that simultaneously reflects cardiopulmonary metabolism and overall function (11). CPET is regarded as the gold standard for predicting risks associated with thoracic surgery and other major operations requiring complex, high-risk anesthesia management (12, 13). Previous studies investigating the predictive value of CPET indicators for postoperative complications following lung resection have predominantly focused on patients undergoing traditional thoracotomy, which is characterized by a large resection range, severe postoperative complications, and relatively high mortality. Considering the growing prevalence of thoracoscopic surgery, in this study, we focused on patients undergoing thoracoscopic lung resection and their postoperative complications to explore the predictive value of preoperative CPET quantitative indicators for complications after thoracoscopic lung resection.
2 Methods
2.1 Study subjects
The cases in this study were sourced from the Department of Thoracic Surgery, Fourth Hospital of Hebei Medical University from April 2023 to October 2024. The included patients were diagnosed with pulmonary nodules or lung space-occupying lesions via chest CT and clinically diagnosed with either lung cancer or “pending investigation of the nature of lung space occupying lesions.” Following thoracic surgery evaluation, they were deemed eligible for lung resection surgery. The inclusion criteria were: (1) aged over 18; (2) had undergone bronchoscopy biopsy or percutaneous lung biopsy and been diagnosed with lung cancer by histopathology, or the nature of the lung space-occupying lesion was to be investigated; (3) the indications for lung resection surgery were clear after clinical judgment; (4) voluntarily completed CPET and signed the informed consent forms before surgery; (5) underwent lung resection for the first time; and (7) complete information.
The exclusion criteria were as follows: (1) individuals with mental disorders and motor disorders; (2) individuals with unstable vital signs before surgery; (3) individuals with various infections, acute metabolic disturbances, or other severe complications before surgery; (4) individuals with a history of cerebral infarction, myocardial infarction, or surgical procedures in the past three months before surgery; (5) individuals diagnosed with malignant tumors other than lung cancer; (6) individuals with absolute contraindications for CPET; and (7) individuals with incomplete information.
The study was approved by the Ethics Committee of the Fourth Hospital of Hebei Medical University (approval number 2025KS101).
2.2 Procedures
The personal information and clinical data of the patients according to inclusion criteria were collected. All included patients underwent CPET within one week before surgery. Preoperative transthoracic echocardiography was routinely performed to assess cardiac structure and function. Baseline cardiovascular history, including arrhythmia, coronary heart disease, and deep vein thrombosis, was documented. Patients did not have to discontinue any daily medication before the CPET examination.
CPET was conducted using a MasterScreen-CPX cardiopulmonary exercise assessment system (Jaeger, Germany) in the symptom-limited maximal incremental CPET exercise mode. The following indicators were collected from the CPET examination: reason for termination of exercise; the percentage of maximal workload at termination relative to the predicted value (maximal workload %pred), peak oxygen uptake (peak VO2), the percentage of peak oxygen uptake relative to the predicted value (peak VO2%pred), the percentage of anaerobic threshold relative to the predicted value (AT %pred), peak heart rate (peak HR), peak metabolic equivalent (peak MET), peak respiratory exchange ratio (peak RER), blood pressure (BP) at rest/peak time, the ventilatory equivalent for carbon dioxide (VE/VCO2 slope), and the ventilatory equivalent for carbon dioxide at the anaerobic threshold (VE/VCO2@AT).
The indications for immediate termination of exercise were as follows: (1) newly emerging or worsening angina pectoris, or dyspnea; (2) ST segment elevation ≥1.0 mm in leads without diagnostic Q waves (excluding V1 and aVR leads); ST segment depression ≥2.0 mm or downsloping depression during exercise, or significant axis deviation; (3) central nervous system symptoms such as ataxia or dizziness, or signs of impending syncope (presyncope); (4) peripheral hypoperfusion such as cyanosis or pallor; (5) symptoms such as fatigue, shortness of breath, wheezing, leg cramps, or muscle and joint pain that prevent continuation of exercise; (6) a decrease in exercise systolic blood pressure ≥10 mmHg compared to the resting state, or an excessive hypertension response; and (7) severe arrhythmias, including sustained ventricular tachycardia, frequent ventricular premature beats, frequent supraventricular tachycardia, frequent paroxysmal ventricular tachycardia, frequent conduction block, or frequent bradyarrhythmias.
2.3 Confirmation of complications
The postoperative complications and follow-up information after discharge of these patients within 30 d postoperatively were collected. The occurrence and prognosis of postoperative cardiopulmonary complications were documented and analyzed, and the correlations between the occurrence of postoperative cardiopulmonary complications and preoperative statistical indicators were investigated.
The cardiorespiratory complications occurring within 30 d postoperatively were recorded. Respiratory complications included: (1) re-intubation or the inability to extubate postoperatively, necessitating transfer to the ICU for mechanical ventilation due to respiratory failure; (2) chest tube duration ≥ 7 d due to prolonged air leak, atelectasis, pleural effusion, etc. (14, 15); (3) pulmonary infection accompanied by changes visible on chest x-ray or chest CT scan; (4) respiratory distress syndrome; and (5) pulmonary embolism. Cardiovascular complications included: (1) myocardial infarction; (2) angina pectoris; (3) heart failure; and (4) arrhythmias requiring treatment. The occurrence of complications was defined as the presence of one or more of the above.
2.4 Data analysis
Statistical analysis was conducted using SPSS 27.0 software. Categorical data were expressed as percentages, while quantitative data were expressed as mean ± standard deviation (x ± s). Chi-square test was employed to compare categorical data. For quantitative data adhering to a normal distribution, independent-sample t-test was used for inter-group comparisons. Mann–Whitney U test was applied for inter-group comparisons of measurement data that did not follow a normal distribution. The CPET indicators with significant differences were stratified and subjected to logistic regression analysis. Statistical significance was indicated by P < 0.05. The sensitivity and specificity of each indicator were also evaluated.
3 Results
3.1 Clinical data and key CPET indicators
We included a total of 397 patients who met the inclusion criteria and were diagnosed with either lung cancer or pulmonary nodules/pulmonary space-occupying lesions requiring surgical intervention. All patients underwent preoperative CPET. Based on the clinical diagnosis and disease stage, thoracic surgeons performed various types and extents of lung resections: 376 patients underwent video-assisted thoracoscopic lung resection (lung wedge resection/segmentectomy/lobectomy with or without lymph node dissection); 19 patients underwent thoracotomy (e.g., conversion from thoracoscopy to open-chest lung resection and thoracotomy with lung resection and lymph node dissection); and two patients underwent total pneumonectomy combined with lymph node dissection. The 21 patients were excluded due to the small number of patients undergoing thoracotomy or total pneumonectomy. Consequently, 376 patients who underwent video-assisted thoracoscopic lung resection were included in the final statistical analysis. The included cases included 162 males and 214 females with a mean age of 62.5 ± 6.1 years.
The postoperative complications were followed up for 30 d, and 52 patients experienced at least one complication. The incidence of cardiorespiratory complications was 13.8%, with a total of 56 occurrences of seven types of complications. There were no fatalities. The frequency of each type of complication is detailed in Table 1.
Comparison between the subgroup without cardiopulmonary complications (NCCP group: 324 cases) and the subgroup with cardiopulmonary complications (CCP group: 52 cases) revealed statistically significant differences in age, extent of lung resection, and lymph node metastasis (P < 0.05); no significant differences between the two groups were observed in other general conditions (P > 0.05). Regarding the CPET indicators, statistically significant differences were observed in peak HR, peak VO2, peak VO2%pred, peak MET, and maximal workload %pred between the two groups (P < 0.05). In contrast, no statistically significant differences were found in AT %pred, VE/VCO2@AT, VE/VCO2 slope, and peak RER between the two subgroups (P > 0.05). The comparison of general conditions and CPET data between the two subgroups is detailed in Table 2.
3.2 CPET indicator thresholds for the prediction of postoperative complications
The indicators exhibiting significant differences between the NCCP and CCP groups following thoracoscopic lung resection were divided into distinct levels. For example, peak VO2 was divided into <20 mL/(min·kg), <15 mL/(min·kg); peak VO2%pred was divided into <80%, <70%, <60%; peak MET was divided into <6, <5, <4; and maximum workload %pred was divided into <80%, <70%, <60%. The incidence of complications at these indicator levels was then compared between the two subgroups. Chi-square test and logistic regression analysis were performed, and the indicators without statistical significance (P > 0.05) were eliminated. The results are shown in Table 3.
3.3 Diagnostic evaluation of CPET indexes
Based on the findings of Section 3.2, the indicator cut-off values resulting in significant differences between the NCCP and CCP groups were analyzed to evaluate the sensitivity, specificity, positive predictive value, and negative predictive value of these parameters at various cut-off levels in predicting postoperative cardiopulmonary complications. As shown in Table 4, the sensitivity and specificity of peak VO2%pred <70%, peak MET <5, and maximal workload %pred <80% both exceeded 60%, with the negative predictive values exceeding 90%. The positive predictive values of peak VO2 < 15 mL/(min·kg), peak VO2%pred <60%, peak MET <4, and maximal workload %pred <60% all exceeded 30%. The diagnostic accuracy and odds ratios (ORs) obtained by categorizing the indicators based on these thresholds are presented in Table 5. The diagnostic accuracy was highest using the following cutoff values of peak VO2 [15 mL/(min·kg)], peak VO2%pred (60%), peak MET (4), and maximal workload %pred (60%), resulting in ORs of 6.2, 4.0, 4.6, and 3.2, respectively.
4 Discussion
The primary postoperative issues among thoracic surgery patients are cardiorespiratory complications, and the decline in cardiopulmonary function is an important cause of postoperative complications in patients after thoracic surgery. The leading cause of mortality is respiratory failure (16). Cardiorespiratory function mensuration is an essential preoperative examination for thoracic surgery and provides a basis for assessing the risk of anesthesia and postoperative complications.
At rest, the heart and lung functions may have compensatory reserve capacity. The distinction between CPET and traditional heart and lung function tests is that CPET focuses on the interaction between heart and lung functions during exercise. Thus, CPET provides a comprehensive reflection of the body's maximum aerobic metabolic capacity and cardiopulmonary reserve capacity, with a particular emphasis on the simultaneous assessment of heart function and lung function. The oxygen demand of thoracic surgery patients increases by 40%−50% after surgery, requiring higher cardiopulmonary reserves to meet the increase in postoperative oxygen consumption (17–19). CPET monitors various cardiopulmonary variables (e.g., ventilation, metabolic indicators, dynamic blood pressure, heart rate, and electrocardiogram parameters) while stressing the entire cardiopulmonary and oxygen delivery system, thereby evaluating cardiopulmonary function and status simultaneously (20). To some extent, CPET mirrors the stresses placed on the heart and lung functions of thoracic surgery patients, who must cope with the increased metabolic demands induced by surgical trauma. Consequently, CPET provides a comprehensive evaluation of cardiopulmonary reserve capacity and tolerance to pulmonary resection (21). CPET has thus become a recommended method for assessing risks related to anesthesia and surgery and particularly for determining suitability for pulmonary resection and risk of perioperative complications (10, 22).
In this study, the incidence of cardiopulmonary complications after video-assisted thoracoscopic lung resection was 13.8%, lower than that observed in previous studies on traditional thoracotomy and lung resection. This reflects the advantages of thoracoscopic lung resection over traditional methods, including reduced release of inflammatory factors, minimalized functional impact, and shortened postoperative hospital stays. In terms of general patient characteristics, patients in the CCP group were older, had a greater extent of lung resection, and were more likely to have had lymph node dissection compared to patients in the NCCP group, consistent with some previous findings (8, 23, 24). We also found that video-assisted thoracoscopic lung resection posed a relatively low risk, with most complications being mild; however, elderly patients or those undergoing a larger scope of resections were still at high risk for postoperative complications. Our results indicated that several core CPET indicators were significant for predicting the incidence of cardiopulmonary complications following thoracoscopic lung resection (P < 0.05): peak HR, peak VO2, peak VO2%pred, MET, and maximal workload %pred. The diagnostic accuracy was highest using the following cut-off values of CPET indicators: peak VO2 of 15 mL/(min·kg), peak VO2%pred of 60%, peak MET of 4, and maximal workload %pred of 60%.
For pulmonary resection, peak VO2 is regarded as the most important indicator for assessing surgical risk. In related studies on pulmonary resection (primarily thoracotomy-based lung resections), patients with peak VO2 < 15 mL/(min·kg) were at increased risk of postoperative complications, and peak VO2 was the most commonly recommended indicator (20, 22, 25–28). Peak VO2%pred is the percentage of a patient's measured peak VO2 value relative to the predicted peak VO2 value of a healthy individual of the same gender and age. Compared with the matched healthy cohort, a higher peak VO2%pred is associated with improved survival and reduced complications (29–32). Our results verify this finding; the risk of postoperative complications was higher for peak VO2%pred <60%. However, the threshold of peak VO2%pred used to assess the risk of lung resection has not been widely validated, potentially due to the limited generalizability of peak VO2%pred values derived from a small matched sample of healthy people (33, 34).
In this study, the peak HR of the CCP subgroup was significantly lower than that of the NCCP subgroup (P < 0.05). Heart rate reserve (HRR) serves as an indicator for assessing cardiac function and heart rate adaptability during exercise. However, in this study, we did not compare the HRR inferred from peak HR. The HRR results were biased due to the termination of exercise in some patients during the exercise process due to myocardial ischemia, arrhythmia, and subjective feelings of leg fatigue. Therefore, no statistical analysis of the predictive value of HRR was conducted. Even so, our findings suggest that patients with inadequate cardiac response to increased exercise loads exhibit a higher risk of complications after thoracoscopic lung resection.
We found a correlation between the maximum exercise load and the incidence of postoperative complications, which aligns with previous findings (35). However, no research consensus has been reached on this relationship. Based on our findings, we recommend using peak VO2 as the primary CPET indicator complemented with maximal workload %pred and MET for a comprehensive preoperative evaluation of risk factors for cardiopulmonary complications. Patients identified as high-risk [e.g., peak VO2 < 15 mL/(min·kg) or peak VO2%pred <60%] may benefit from enhanced postoperative monitoring in intensive care units, routine assessment of cardiac biomarkers such as troponin and pro-BNP, and careful reconsideration of surgical indications.
Although lower AT is associated with higher morbidity and mortality in abdominal, vascular, transplant and bariatric surgeries (36), we did not find a similar correlation for pulmonary resection. In our study, VE/VCO2@AT and VE/VCO2 slope were higher in the postoperative CCP subgroup than in the NCCP subgroup, although the differences were not statistically significant (P > 0.05). Recent studies have suggested that VE/VCO2 slope can predict postoperative cardiopulmonary complications and mortality (37) and can be regarded as an independent predictor of postoperative mortality (38–40). Our study failed to confirm this relationship point due to several limitations: the relatively good general condition of the enrolled population, the relatively small scope of surgical resection, and the low mortality rate (no deaths occurred within 30 d in our enrolled population). Further validation should be conducted in a broader population with an extended follow-up period.
The spirometry and diffusion capacity of the lung for carbon monoxide are almost universally used as important indicators by thoracic surgeons. Patients whose test results fall below the threshold values are further assessed by low-tech exercise tests (41); however, CPET is still considered as the gold standard for evaluating cardiopulmonary metabolic function and predicting the risks associated with pulmonary resection (11–13, 42–44). However, Clark et al. found that few thoracic surgeons strictly complied with American College of Chest Physicians guidelines (45).
Additionally, it is worth noting that arrhythmia and pulmonary infection were the most common postoperative complications in our study. Thus, even though more serious cardiopulmonary complications attract the most attention, the potential risks of arrhythmia and pulmonary infection cannot be ignored, especially for high-risk patients. In these cases, it is important to prepare a response plan for cardiopulmonary complications in advance.
4.1 Limitations of the study
Early screening for lung cancer enables early lesion detection, thereby reducing the scope of surgical resection and allowing the application of thoracoscopic surgical approaches. Thus, early screening significantly reduces the occurrence of postoperative complications and allows some elderly lung cancer patients who cannot tolerate thoracotomy to receive radical treatment. Due to the limited number of cases with large resection scope and thoracotomy, these patients were excluded from the study, leading to a certain bias. In addition, the overall condition and cardiopulmonary function of the enrolled patients in this study were generally good. The conditions of some patients were classified as contraindications because of old age, poor general condition, and poor cardiac and/or pulmonary function with obvious clinical symptoms. Others declined testing because they were unable to cooperate. As a result, few patients with poor CPET indicators were included. Intraoperative variables such as operative duration and intraoperative complications were not included in the analysis. These factors may independently contribute to postoperative complications and should be considered in future studies. Future research is needed that includes more patients with large lung resection scopes and poor cardiopulmonary function, providing a more comprehensive reference for the prediction of complications after lung resection.
5 Conclusion
The results of this study suggest that certain CPET-based preoperative indicators can predict the risk of postoperative complications among patients with generally good cardiopulmonary function and relatively mild postoperative complications. Patients with peak VO2 < 15 mL/(min·kg) or peak VO2%pred <60% during preoperative CPET examination were found to be at increased risk of postoperative complications. These indicators can be used for the preoperative stratification of patients scheduled for video-assisted thoracoscopic lung resection. Combining these indicators with maximal workload %pred and MET during pre-surgical assessments can help thoracic surgeons formulate preventive measures or prepare for potential postoperative complications.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving humans were approved by Ethics Committee of the Fourth Hospital of Hebei Medical University. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants' legal guardians/next of kin in accordance with the national legislation and institutional requirements. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
NY: Methodology, Writing – original draft, Formal analysis, Data curation. ZS: Writing – original draft, Investigation. JL: Project administration, Supervision, Conceptualization, Writing – review & editing, Funding acquisition. YY: Writing – review & editing, Methodology, Conceptualization.
Funding
The author(s) declared that financial support was not received for this work and/or its publication.
Conflict of interest
The author(s) declared that the research this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A, et al. Cancer statistics, 2025. CA Cancer J Clin. (2025) 75:10–45. doi: 10.3322/caac.21871
2. Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. (2024) 4:47–53. doi: 10.1016/j.jncc.2024.01.006
3. Yang M, Ahn HJ, Kim K, Kim JA, Yi CA, Kim MJ, et al. Does a protective ventilation strategy reduce the risk of pulmonary complications after lung cancer surgery?: a randomized controlled trial. Chest. (2011) 139:530–7. doi: 10.1378/chest.09-2293
4. Ferguson MK, Gaissert HA, Grab JD, Sheng S. Pulmonary complications after lung resection in the absence of chronic obstructive pulmonary disease: the predictive role of diffusing capacity. J Thorac Cardiovasc Surg. (2009) 138:1297–302. doi: 10.1016/j.jtcvs.2009.05.045
5. Bernard A, Deschamps C, Allen MS, Miller DL, Trastek VF, Jenkins GD, et al. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J Thorac Cardiovasc Surg. (2001) 121:1076–82. doi: 10.1067/mtc.2001.114350
6. Villamizar NR, Darrabie MD, Burfeind WR, Petersen RP, Onaitis MW, Toloza E, et al. Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy. J Thorac Cardiovasc Surg. (2009) 138:419–25. doi: 10.1016/j.jtcvs.2009.04.026
7. Marret E, Miled F, Bazelly B, Metaoua S El, de Montblanc J, Quesnel C, et al. Risk and protective factors for major complications after pneumonectomy for lung cancer. Interact Cardiovasc Thorac Surg. (2010) 10:936–9. doi: 10.1510/icvts.2009.231621
8. Gagné S, McIsaac DI. Modifiable risk factors for patients undergoing lung cancer surgery and their optimization: a review. J Thorac Dis. (2018) 10:S3761–72. doi: 10.21037/jtd.2018.10.04
9. Brioude G, Gust L, Thomas PA, D'Journo XB. Postoperative complications after major lung resection. Rev Mal Respir. (2019) 36:720–37. doi: 10.1016/j.rmr.2018.09.004
10. Choi H, Mazzone P. Preoperative evaluation of the patient with lung cancer being considered for lung resection. Curr Opin Anaesthesiol. (2015) 28:18–25. doi: 10.1097/ACO.0000000000000149
11. Herdy AH, Ritt LE, Stein R, Araújo CG, Milani M, Meneghelo RS, et al. Cardiopulmonary exercise test: background, applicability and interpretation. Arq Bras Cardiol. (2016) 107:467–81. doi: 10.5935/abc.20160171
12. Azzi M, Debeaumont D, Bonnevie T, Aguilaniu B, Cerasuolo D, Boujibar F, et al. Evaluation of the 3-minute chair rise test as part of preoperative evaluation for patients with non-small cell lung cancer. Thorac Cancer. (2020) 11:2431–9. doi: 10.1111/1759-7714.13548
13. Salati M, Brunelli A. Risk stratification in lung resection. Curr Surg Rep. (2016) 4:37. doi: 10.1007/s40137-016-0158-x
14. Orsini B, Baste JM, Gossot D, Berthet JP, Assouad J, Dahan M, et al. Index of prolonged air leak score validation in case of video-assisted thoracoscopic surgery anatomical lung resection: results of a nationwide study based on the French national thoracic database, EPITHOR. Eur J Cardiothorac Surg. (2015) 48:608–11. doi: 10.1093/ejcts/ezu505
15. Wood DE, Lauer LM, Layton A, Tong KB. Prolonged length of stay associated with air leak following pulmonary resection has a negative impact on hospital margin. Clinicoecon Outcomes Res. (2016) 8:187–95. doi: 10.2147/CEOR.S95603
16. Mao Y, Zhang D, Zhang R, Wang L, Sun K, Yang L. Postoperative respiratory failure in surgically treated patients with lung cancer and poor pulmonary function. Chin J Thorac Cardiovasc Surg. (2003) 19:151–3.
17. Older P, Smith R, Courtney P, Hone R. Preoperative evaluation of cardiac failure and ischemia in elderly patients by cardiopulmonary exercise testing. Chest. (1993) 104:701–4. doi: 10.1378/chest.104.3.701
18. Stringer WW. Cardiopulmonary exercise testing: current applications. Expert Rev Respir Med. (2010) 4:179–88. doi: 10.1586/ers.10.8
19. Shulman MA, Myles PS, Chan MT, McIlroy DR, Wallace S, Ponsford J. Measurement of disability-free survival after surgery. Anesthesiology. (2015) 122:524–36. doi: 10.1097/ALN.0000000000000586
20. Kallianos A, Rapti A, Tsimpoukis S, Charpidou A, Dannos I, Kainis E, et al. Cardiopulmonary exercise testing (CPET) as preoperative test before lung resection. In Vivo. (2014) 28:1013–20.25398794
21. Albouaini K, Egred M, Alahmar A, Wright DJ. Cardiopulmonary exercise testing and its application. Postgrad Med J. (2007) 83:675–82. doi: 10.1136/hrt.2007.121558
22. Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. (2007) 132:161S–77. doi: 10.1378/chest.07-1359
23. Lederman D, Easwar J, Feldman J, Shapiro V. Anesthetic considerations for lung resection: preoperative assessment, intraoperative challenges and postoperative analgesia. Ann Transl Med. (2019) 7:356. doi: 10.21037/atm.2019.03.67
24. Thomas DC, Blasberg JD, Arnold BN, Rosen JE, Salazar MC, Detterbeck FC, et al. Validating the thoracic revised cardiac risk Index following lung resection. Ann Thorac Surg. (2017) 104:389–94. doi: 10.1016/j.athoracsur.2017.02.006
25. British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS Guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax. (2001) 56:89–108. doi: 10.1136/thorax.56.2.89
26. Jones LW, Watson D, Herndon JE, Eves ND, Haithcock BE, Loewen G, et al. Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer. Cancer. (2010) 116:4825–32. doi: 10.1002/cncr.25396
27. Bayram AS, Candan T, Gebitekin C. Preoperative maximal exercise oxygen consumption test predicts postoperative pulmonary morbidity following major lung resection. Respirology. (2007) 12:505–10. doi: 10.1111/j.1440-1843.2007.01097.x
28. Bobbio A, Chetta A, Internullo E, Ampollini L, Carbognani P, Bettati S, et al. Exercise capacity assessment in patients undergoing lung resection. Eur J Cardiothorac Surg. (2009) 35:419–22. doi: 10.1016/j.ejcts.2008.11.004
29. Roy PM. Preoperative pulmonary evaluation for lung resection. J Anaesthesiol Clin Pharmacol. (2018) 34:296–300. doi: 10.4103/joacp.JOACP_89_17
30. Brutsche MH, Spiliopoulos A, Bolliger CT, Licker M, Frey JG, Tschopp JM. Exercise capacity and extent of resection as predictors of surgical risk in lung cancer. Eur Respir J. (2000) 15:828–32. doi: 10.1034/j.1399-3003.2000.15e03.x
31. Win T, Jackson A, Sharples L, Groves AM, Wells FC, Ritchie AJ, et al. Cardiopulmonary exercise tests and lung cancer surgical outcome. Chest. (2005) 127:1159–65. doi: 10.1016/S0012-3692(15)34462-7
32. Loewen GM, Watson D, Kohman L, Herndon JE II, Shennib H, Kernstine K, et al. Preoperative exercise VO2 measurement for lung resection candidates: results of cancer and leukemia group B protocol 9238. J Thorac Oncol. (2007) 2:619–25. doi: 10.1097/JTO.0b013e318074bba7
33. Rapp D, Scharhag J, Wagenpfeil S, Scholl J. Reference values for peak oxygen uptake: cross-sectional analysis of cycle ergometry-based cardiopulmonary exercise tests of 10090 adult German volunteers from the prevention first registry. BMJ Open. (2018) 8:e018697. doi: 10.1136/bmjopen-2017-018697
34. Chiaranda G, Myers J, Arena R, Kaminsky L, Sassone B, Pasanisi G, et al. Improved percent-predicted peak VO2 is associated with lower risk of hospitalization in patients with coronary heart disease. Analysis from the FRIEND registry. Int J Cardiol. (2020) 310:138–44. doi: 10.1016/j.ijcard.2020.02.057
35. Benzo R, Kelley GA, Recchi L, Hofman A, Sciurba F. Complications of lung resection and exercise capacity: a meta-analysis. Respir Med. (2007) 101:1790–7. doi: 10.1016/j.rmed.2007.02.012
36. Moran J, Wilson F, Guinan E, McCormick P, Hussey J, Moriarty J. Role of cardiopulmonary exercise testing as a risk-assessment method in patients undergoing intra-abdominal surgery: a systematic review. Br J Anaesth. (2016) 116:177–91. doi: 10.1093/bja/aev454
37. Wilson RJT, Yates DRA, Walkington JP, Davies SJ. Ventilatory inefficiency adversely affects outcomes and longer-term survival after planned colorectal cancer surgery. Br J Anaesth. (2019) 123:238–45. doi: 10.1016/j.bja.2019.01.032
38. Torchio R, Guglielmo M, Giardino R, Ardissone F, Ciacco C, Gulotta C, et al. Exercise ventilatory inefficiency and mortality in patients with chronic obstructive pulmonary disease undergoing surgery for non-small-cell lung cancer. Eur J Cardiothorac Surg. (2010) 38:14–9. doi: 10.1016/j.ejcts.2010.01.032
39. Brunelli A, Belardinelli R, Pompili C, Xiumé F, Refai M, Salati M, et al. Minute ventilation-to-carbon dioxide output (VE/VCO2) slope is the strongest predictor of respiratory complications and death after pulmonary resection. Ann Thorac Surg. (2012) 93:1802–6. doi: 10.1016/j.athoracsur.2012.03.022
40. Torchio R, Mazzucco A, Guglielmo M, Giardino R, Ciacco C, Ardissone F. Minute ventilation to carbon dioxide output (V'E/V'CO2 slope) is the strongest death predictor before larger lung resections. Monaldi Arch Chest Dis. (2017) 87:817. doi: 10.4081/monaldi.2017.817
41. Marjanski T, Wnuk D, Dziedzic R, Ostrowski M, Sawicka W, Marjanska E, et al. Physiological biomarkers assessed by low-tech exercise tests predict complications and overall survival in patients undergoing pneumonectomy due to lung cancer. Cancers (Basel). (2021) 13:735. doi: 10.3390/cancers13040735
42. Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: diagnosis and management of lung cancer, 3rd ed: american college of chest physicians evidence-based clinical practice guidelines. Chest. (2013) 143:e166S–190. doi: 10.1378/chest.12-2395
43. Ferrazza AM, Martolini D, Valli G, Palange P. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration. (2009) 77:3–17. doi: 10.1159/000186694
44. Agnew N. Preoperative cardiopulmonary exercise testing. BJA CEPD Reviews. (2010) 10:33–7. doi: 10.1093/bjaceaccp/mkq001
Keywords: cardiopulmonary complications, cardiopulmonary exercise testing, maximal workload, metabolic equivalent, peak heart rate, peak oxygen uptake, thoracoscopic lung resection
Citation: Yang N, Shi Z, Liu J and Yuan Y (2026) Key cardiopulmonary exercise testing indicators for predicting the risk of postoperative cardiopulmonary complications in patients undergoing thoracoscopic lung resection. Front. Surg. 12:1765398. doi: 10.3389/fsurg.2025.1765398
Received: 11 December 2025; Revised: 23 December 2025;
Accepted: 24 December 2025;
Published: 13 January 2026.
Edited by:
Francesco Zaraca, Ospedale di Bolzano, ItalyReviewed by:
Gabriella Roca, University of Padua, ItalyGiorgio Cannone, Padua University Hospital, Italy
Copyright: © 2026 Yang, Shi, Liu and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yadong Yuan, eXVhbnlkMTEwOEAxNjMuY29t
Nan Yang1